BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38707772)

  • 21. IL-33/ST2 Activation Is involved in Ro60-Regulated Photosensitivity in Cutaneous Lupus Erythematosus.
    Song Y; Wei F; Liu Y; Han F; Ma L; Zhuang Y; Pan C; Jia Z; Gong A
    Mediators Inflamm; 2022; 2022():4955761. PubMed ID: 35909659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
    Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
    Front Immunol; 2021; 12():775353. PubMed ID: 34868043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
    Robinson ES; Werth VP
    Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
    DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I
    Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonself RNA rewires IFN-β signaling: A mathematical model of the innate immune response.
    Korwek Z; Czerkies M; Jaruszewicz-Błońska J; Prus W; Kosiuk I; Kochańczyk M; Lipniacki T
    Sci Signal; 2023 Dec; 16(815):eabq1173. PubMed ID: 38085817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
    Zhou X; Yan J; Lu Q; Zhou H; Fan L
    Scand J Immunol; 2021 Jan; 93(1):e12933. PubMed ID: 32654170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon.
    Han S; Zhuang H; Lee PY; Li M; Yang L; Nigrovic PA; Reeves WH
    Arthritis Rheumatol; 2020 Jan; 72(1):100-113. PubMed ID: 31390156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Interferon-Stimulated Response Elements Cooperatively Regulate Interferon-Stimulated Gene Expression in West Nile Virus-Infected IFNAR
    Cui D; Espínola EE; Arora K; Brinton MA
    J Virol; 2021 Oct; 95(22):e0104021. PubMed ID: 34495694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus.
    Liu Y; Xu M; Min X; Wu K; Zhang T; Li K; Xiao S; Xia Y
    Front Immunol; 2017; 8():651. PubMed ID: 28620393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
    Erazo-Martínez V; Tobón GJ; Cañas CA
    Autoimmun Rev; 2023 Feb; 22(2):103262. PubMed ID: 36563771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus.
    Furukawa F; Kashihara-Sawami M; Lyons MB; Norris DA
    J Invest Dermatol; 1990 Jan; 94(1):77-85. PubMed ID: 2132545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.
    Dempoya J; Matsumiya T; Imaizumi T; Hayakari R; Xing F; Yoshida H; Okumura K; Satoh K
    J Virol; 2012 Dec; 86(23):12760-9. PubMed ID: 22973045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon alpha and beta receptor 1 knockout in human embryonic kidney 293 cells enhances the production efficiency of proteins or adenoviral vectors related to type I interferons.
    Kim A; Park JH; Lee MJ; Kim SM
    Front Bioeng Biotechnol; 2023; 11():1192291. PubMed ID: 37476482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultraviolet B irradiation decreases CXCL10 expression in keratinocytes through endoplasmic reticulum stress.
    Ohnishi T; Hisadome M; Joji K; Chiba N; Amir MS; Kanekura T; Matsuguchi T
    J Cell Biochem; 2021 Apr; ():. PubMed ID: 33909926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in cutaneous lupus.
    Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
    J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.